TY  - JOUR
AU  - Guasch, Montserrat
AU  - Cañete, Fiorella
AU  - Ordas, Ingrid
AU  - Iglesias-Flores, Eva
AU  - Clos, Ariadna
AU  - Gisbert, Javier P
AU  - Taxonera, Carlos
AU  - Vera, Isabel
AU  - Minguez, Miguel
AU  - Guardiola, Jordi
AU  - Rivero, Montserrat
AU  - Nos, Pilar
AU  - Gomollon, Fernando
AU  - Barrio, Jesus
AU  - de Francisco, Ruth
AU  - Lopez-Sanroman, Antonio
AU  - Martin-Arranz, M Dolores
AU  - Garcia-Planella, Esther
AU  - Camargo, Raquel
AU  - Garcia-Lopez, Santiago
AU  - de Castro, Luisa
AU  - Calvet, Xavier
AU  - Esteve, Maria
AU  - Mañosa, Míriam
AU  - Domenech, Eugeni
PY  - 2020
DO  - 10.1111/jgh.15084
UR  - http://hdl.handle.net/10668/15469
T2  - Journal of gastroenterology and hepatology
AB  - Biological therapies may be changing the natural history of inflammatory bowel diseases (IBDs), reducing the need for surgical intervention. We aimed to assess whether the availability of anti-TNF agents impacts the need for early surgery in Crohn's...
LA  - en
PB  - Elsevier
KW  - Anti-TNF
KW  - Immunosuppressants
KW  - Inflammatory bowel disease
KW  - Surgery
KW  - Adult
KW  - Age Factors
KW  - Biological Factors
KW  - Colitis, Ulcerative
KW  - Crohn Disease
KW  - Disease-Free Survival
KW  - Female
KW  - Gastrointestinal Agents
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Infliximab
KW  - Male
KW  - Middle Aged
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Time Factors
KW  - Tumor Necrosis Factor-alpha
KW  - Young Adult
TI  - Changes in the requirement for early surgery in inflammatory bowel disease in the era of biological agents.
TY  - research article
VL  - 35
ER  -